ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis - United States - 2023-2029 - MedSuite - Includes: ENT Endoscopes, ENT Powered Instruments, and 9 more
The U.S. market for ENT endoscopic and bronchoscopic devices exhibited a valuation of approximately $1.2 billion in 2022. Projections indicate steady growth during the forecast period, with a compound annual growth rate (CAGR) of 3.8%. By the end of the forecast period, the market is expected to surpass $1.6 billion.
The comprehensive report suite covering the U.S. market for ENT endoscopic and bronchoscopic devices encompasses a range of products. These include ENT endoscopes, ENT powered instruments, ENT hand instruments, ENT surgical energy devices, balloon dilation devices, drug-eluting stents, bronchoscopes, bronchoscopic hand instruments, tracheobronchial stents, bronchoscopic biopsy devices, and foreign body removal devices.
MARKET DATA INCLUDEDUnit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2027, and Historical Data to 2017
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
PROCEDURE NUMBERSIn 2022, there was a notable uptick in the number of ENT procedures conducted in the United States compared to the previous year. Among the procedures performed, sinus procedures saw growth, which encompassed endoscopic sinus procedures, septoplasty, and turbinate reductions. Additionally, ear procedures such as tympanoplasty, mastoidectomy, and myringotomy were carried out. Throat procedures, including tonsillectomies and adenoidectomies, were also part of the overall increase in ENT procedures.
U.S. ENT DEVICE MARKET INSIGHTSThe ENT endoscopic and bronchoscopic device market has witnessed a growing popularity of single-use devices, particularly single-use endoscopes and bronchoscopes. The advantages of these devices are evident, as they offer a decreased risk of infection and eliminate the need for reprocessing after use. Notably, the bronchoscope market has experienced a substantial surge in the adoption of single-use devices. This increasing preference for single-use devices reflects their significant benefits and their potential to enhance patient safety in the field of bronchoscopy.
U.S. ENT DEVICE MARKET SHARE INSIGHTSIn 2022, the leading competitor in the overall ENT endoscopic and bronchoscopic device market was Acclarent. The company participated solely in the balloon dilation device segment of the ENT endoscopic device market, where it held a majority share.
MARKET SEGMENTATION SUMMARY Procedure Volumes for ENT and Bronchoscopy Procedures – MedPro – Using a number of databases, internal and external, we’re able to provide you with the total volume of ENT procedures being performed for each of the markets mentioned in this suite of reports.
ENT Endoscope Market – MedCore – Segmented into 2 main markets: rigid ENT endoscopes and flexible ENT endoscopes.
ENT Powered Instrument Market – MedCore – Segmented into 2 main markets: ENT powered instrument capital equipment and ENT powered instrument disposables.
ENT Hand Instrument Market – MedCore – This market covers several types ENT of hand instruments including sinus hand instruments, laryngeal hand instruments, and otology hand instruments.
ENT Surgical Energy Device Market – MedCore – Segmented into 2 main markets: capital equipment and disposable probes.
Balloon Dilation Device Market – MedCore – This analysis considers only the balloon catheter components of BSD and excludes all other components of a BSD system.
Drug-Eluting Stent Market – MedCore
Bronchoscope Market – MedCore – Segmented into 3 main markets: rigid bronchoscopes, flexible bronchoscopes and ultrasound bronchoscopes.
Bronchoscopic Hand Instrument Market – MedCore
Tracheobronchial Stent Market – MedCore – Segmented into 2 main markets: metal tracheobronchial stents and silicone tracheobroncial stents
Foreign Body Removal Market – MedCore – Segmented into 2 main markets: reusable and disposable devices.
RESEARCH SCOPE SUMMARYRegion: North America (United States)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.